News

Bright Minds Biosciences Showcases Presentations at Global Conferences

Bright Minds Biosciences Showcases Presentations at Global Conferences

Bright Minds Biosciences Highlights Upcoming Conference Presentations

Bright Minds Biosciences, Inc. (NASDAQ: DRUG), is a leader in the biotechnology field, specializing in the development of innovative treatments for challenging neurological and psychiatric disorders. With a commitment to addressing the needs of patients suffering from conditions such as epilepsy and depression, the company is set to present at several notable events.

Scheduled Conference Appearances

The following is a list of conferences where Bright Minds Biosciences will be making presentations:

International Epilepsy Congress

Bright Minds will participate in the 36th International Epilepsy Congress taking place at the Lisboa Congress Centre. This event offers a vital opportunity to share insights and advancements in the treatment of epilepsy with fellow professionals and stakeholders in the field.

Cantor Global Healthcare Conference

Another key event on the schedule is the Cantor Global Healthcare Conference, set for September 5, 2025. Bright Minds will feature prominently in discussions and presentations at this event, showcasing its innovative research and commitment to patient care. The live webcast of this event will be accessible on their official website, allowing shareholders and interested parties to engage with the company's developments.

H.C. Wainwright Annual Global Investment Conference

On September 9, 2025, Bright Minds will also attend the H.C. Wainwright 27th Annual Global Investment Conference to expand its investor outreach efforts and discuss its financial strategy, including the progress of its drug candidates. This platform aids in aligning investor expectations with the company's visionary goals.

Baird Global Healthcare Conference

Furthering engagement in the healthcare investment community, Bright Minds will present at the Baird 2025 Global Healthcare Conference on September 10, 2025. This conference is instrumental in fostering relationships with potential investors and industry partners, enhancing market visibility and opportunity.

Innovative Approach to Therapeutics

At the heart of Bright Minds Biosciences' mission is a robust pipeline of unique compounds designed to target crucial receptors in the brain. The focus is on developing highly selective 5-HT2 agonists which offer promise in treating drug-resistant forms of epilepsy and other central nervous system disorders. Their commitment to addressing high unmet medical needs sets them apart in the crowded biotechnology landscape.

The Company’s Vision

Through its proprietary platform, Bright Minds is dedicated to delivering breakthrough therapies that can significantly change the lives of patients. The company's advancements hinge on rigorous research paired with innovative drug development, focusing primarily on the neurological and psychiatric fields.

Investor Relations Contact

For inquiries related to investments and corporate communications, Bright Minds encourages stakeholders to reach out to their Investor Relations team. Lisa M. Wilson, their designated contact, is available at 212-452-2793 or via email. Additionally, Alex Vasilkevich, the Chief Operating Officer, welcomes direct engagement regarding operational matters.

Frequently Asked Questions

What is the primary focus of Bright Minds Biosciences?

The primary focus of Bright Minds Biosciences is developing highly selective 5-HT2 agonists for treating various neurological and psychiatric disorders.

What upcoming conferences will Bright Minds attend?

Bright Minds will present at the International Epilepsy Congress and several key healthcare conferences in September 2025.

How can investors follow Bright Minds' presentations?

Investors can access live webcasts of presentations on the Bright Minds official website and view archived content after events.

What therapeutic areas does Bright Minds target?

Bright Minds focuses on therapies for epilepsy, depression, and other central nervous system disorders where there are significant unmet clinical needs.

How can I contact Bright Minds for further questions?

You can contact Bright Minds' investor relations directly through Lisa M. Wilson at 212-452-2793 or via email for any inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MGM China Hits Record Highs Amid Market Challenges

Updated Category News Views 59

Highs Amid Headwinds: MGM China's Standout Quarter Rolling into one's portfolio, MGM China isn't just coasting along—it's smashing some records, despite fierce headwinds. It's not all smooth sailing in Macau's gaming scene, but MGM China has hammered out its third-quarter results with gusto, setting new records for revenue and adjusted EBITDA. These folks aren't just...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 132

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 125

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Follett's $2.5M Investment Revamps UF Bookstore Experience

Updated Category News Views 44

A New Era for the UF Bookstore If you've ever strolled through a dusty college bookstore and found yourself yearning for a bit of flair, Gainesville has got a surprise for you. The University of Florida, in collaboration with Follett Higher Education, just splashed $2.5 million to turn their bookstore into a dazzling retail wonderland. Not just about flogging textbooks...

Continue Reading
Vicuna Air Unveils Pet-Friendly European Routes

Updated Category News Views 12

Paws in the Sky: Vicuna Air's New Venture Look, when you hear about airlines, you're usually thinking delays, cramped seats, and overpriced peanuts—not four-legged companions jet-setting across the Atlantic. Yet, here comes Vicuna Air, flipping the script with their first continental European flights this October. They've got an ace up their sleeve: Brussels, now a...

Continue Reading
Ryde Group Faces Class Action: Key Investor Takeaways

Updated Category News Views 62

Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...

Continue Reading
MPLX Adds Industry Veterans to Board Leadership

Updated Category News Views 25

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

Continue Reading
Tata's $450M Bet on India's AI Infrastructure

Updated Category News Views 28

The Big Bet on AI Infrastructure Here comes Tata Communications, tossing nearly USD 450 million into the pot, betting on a vision that could change India's digital backbone. This isn't just some drop in the bucket; they're talking about laying down 10,000 kilometers of fiber for India's AI super highway. It's a gutsy move, and frankly, it's about time someone shook things...

Continue Reading
Historic Williamsburg Loft Gets a Modern Makeover

Updated Category News Views 0

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 66

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading

Top 5 Most Recently Viewed Articles

Plaza Retail REIT to Host Conference Call on Financial Results

Updated Category News Views 153

Plaza Retail REIT Announces Financial Results Conference Call Plaza Retail REIT, recognized as a leading retail property owner and developer, is excited to announce a live conference call with its senior management team. This upcoming event will focus on discussing the company's financial results for the third quarter of 2025. The call is set to take place on Thursday,...

Continue Reading
Shimmick Corporation Second Quarter Update: Growth and Strategy

Updated Category News Views 114

Shimmick Corporation Reports Strong Financial Performance In a recent announcement, Shimmick Corporation (NASDAQ: SHIM), a prominent infrastructure solutions provider, revealed its financial results for the second quarter. The company has shown remarkable growth in various projects aimed at enhancing water, climate resilience, energy transition, and sustainable...

Continue Reading
Canadian Cannabis Exports Expand Globally with PR Expertise

Updated Category News Views 158

The Global Expansion of Canadian Cannabis Companies Canada is establishing itself as a frontrunner in the international medical cannabis market. As producers look to broaden their horizons, the need for strategic communication becomes essential. With the legalization of cannabis on a federal level, Canadian companies are well-positioned to meet the growing global demand...

Continue Reading
Autolus Therapeutics: Key Developments Boosting Stock Value

Updated Category News Views 143

Positive Developments for Autolus Therapeutics' Stock The recent news from the U.K.'s National Institute for Health and Care Excellence has ignited interest in Autolus Therapeutics plc (NASDAQ: AUTL). The organization has released draft guidance that endorses the use of Aucatzyl (obecabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor...

Continue Reading
Revolutionizing Digital Security in Australia and New Zealand

Updated Category News Views 205

Cyabra Partners with Aquion for Enhanced Digital Security New York, NY, April 09, 2025 -- Cyabra Strategy Ltd. (“Cyabra”), a renowned platform specializing in real-time disinformation detection, has forged a significant partnership with Aquion Pty Ltd, a reliable distributor of cybersecurity solutions. This collaboration aims to deploy Cyabra’s cutting-edge AI...

Continue Reading